The duration of treatment with GLP-1 medications is personalised and depends on your individual goals, response to treatment, and medical needs.
Short-term vs Long-term use
- Weight loss phase: Typically 6-12 months to reach your target weight
- Maintenance phase: Can continue for as long as medically appropriate
Clinical guidelines
- These medications are safe for long-term use based on current evidence
- There is no maximum time limit as long as the benefits outweigh any risks
- You can remain on the medication as long as your BMI doesn't drop below 20
Considerations for duration
- Whether you've achieved your weight loss goals
- How well you're tolerating the medication
- Your ability to maintain weight loss without medication
- Development of any contraindications during treatment
Stopping treatment
- Should be discussed with your prescriber
- Some patients benefit from a gradual dose reduction rather than stopping abruptly
- Weight regain is possible after stopping, but can be minimised with proper planning
Remember, obesity is now recognised as a chronic condition that may require long-term management. Your prescriber will work with you to determine the best treatment duration for your specific situation.